| risperidone / Generic mfg. |
NCT00253110: A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder |
|
|
| Completed | 4 | 396 | US | risperidone, haloperidol | Janssen, LP | Schizophrenia, Schizoaffective Disorder | | 09/98 | | |
NCT00378183: A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. |
|
|
| Completed | 4 | 120 | US | risperidone | Janssen, LP | Schizoaffective Disorder, Schizophrenia | | 05/02 | | |
NCT00034905: A Comparison of Seroquel vs. Risperidone in Schizophrenia |
|
|
| Completed | 4 | | US | quetiapine fumarate vs risperidone | AstraZeneca | Schizophrenia | 09/02 | 09/02 | | |
NCT00249171: A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients |
|
|
| Completed | 4 | 226 | Europe | risperidone | Janssen Pharmaceutica N.V., Belgium | Schizophrenia, Psychotic Disorders, Emergency Treatment | | 02/03 | | |
NCT00236379: A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 4 | 59 | US | Olanzapine, Risperidone | Janssen, LP | Schizophrenia, Diabetes Mellitus | | 08/03 | | |
NCT00485498: Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics |
|
|
| Completed | 4 | 122 | RoW | Olanzapine Hydrochloride, Risperidone | Eli Lilly and Company | Schizophrenia | | 12/03 | | |
NCT00061802: Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 4 | 225 | US, Europe, RoW | risperidone, quetiapine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Schizophrenia, Schizoaffective Disorder | | 02/04 | | |
NCT00261430: A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone. |
|
|
| Completed | 4 | 650 | US | GAIN Acceptance Approach | Janssen, LP | Schizophrenia | | 10/04 | | |
NCT00159081: One Year Drug Treatment in First-Episode Schizophrenia |
|
|
| Completed | 4 | 159 | Europe | Haloperidol, Risperidone (drug) | Heinrich-Heine University, Duesseldorf, German Federal Ministry of Education and Research, German Research Network On Schizophrenia, Janssen-Cilag Ltd., University of Bonn, Humboldt-Universität zu Berlin, University of München, University of Göttingen, University of Cologne, Mainz University, University Hospital Tuebingen, Universität Duisburg-Essen, University of Mannheim, University of Jena, Martin-Luther-Universität Halle-Wittenberg, RWTH Aachen University, University of Wuerzburg | Schizophrenia | 06/05 | 06/05 | | |
NCT00208143: Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia |
|
|
| Completed | 4 | 20 | US | Quetiapine, Risperidone | Creighton University, AstraZeneca | Schizophrenia, Schizoaffective Disorder, Substance Abuse, Substance Dependence | | 12/05 | | |
NCT00108368: The Effects of Risperidone and Olanzapine on Thinking |
|
|
| Completed | 4 | | US | Risperidone, Olanzapine | US Department of Veterans Affairs, Janssen, LP | Schizophrenia, Psychotic Disorders | | 03/06 | | |
NCT00254241: Safety and Efficacy of Seroquel in First Episode Schizophrenia |
|
|
| Completed | 4 | 80 | Europe | Seroquel and Risperidone | AstraZeneca | Schizophrenia | | 06/06 | | |
NCT00314613: Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal |
|
|
| Terminated | 4 | 30 | US | Antipsychotic/Risperidone Consta | Duke University, Janssen, LP | Schizophrenia | 12/06 | | | |
NCT00232687: A Switch Study of BMS-337039 in Schizophrenic Out-patients |
|
|
| Completed | 4 | 450 | Europe | Aripiprazole, Abilify | Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical | Schizophrenia | 04/07 | 04/07 | | |
NCT00216632: A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) |
|
|
| Completed | 4 | 99 | Europe | risperidone | Janssen Pharmaceutica N.V., Belgium | Schizophrenia, Psychotic Disorders | 07/07 | 07/07 | | |
NCT00231335: Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia |
|
|
| Completed | 4 | 30 | US | escitalopram | Emory University, Forest Laboratories | Schizophrenia, Schizoaffective Disorder | | 07/07 | | |
NCT00287820: Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism |
|
|
| Completed | 4 | 46 | US | Olanzapine, ayprexa, olanzapine, zyprexa, risperidone, riperidal | Nathan Kline Institute for Psychiatric Research, Eli Lilly and Company | Schizophrenia, Diabetes, Metabolic Syndrome, Hyperglycemia | | 09/07 | | |
NCT00325689: Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. |
|
|
| Completed | 4 | 323 | US | Quetiapine or Risperidone + Aripiprazole, Abilify, Quetiapine or Risperidone + placebo | Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical | Schizophrenia, Schizoaffective Disorder | 10/07 | 10/07 | | |
NCT00337662: Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia |
|
|
| Completed | 4 | 628 | US, RoW | olanzapine, LY170053, Zyprexa, risperidone | Eli Lilly and Company | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder | 12/07 | 12/07 | | |
NCT00190749: Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder |
|
|
| Completed | 4 | 130 | US | olanzapine, LY170053, Zyprexa, risperidone | Eli Lilly and Company | Schizophrenia, Schizoaffective Disorder | 06/08 | 06/08 | | |
NCT00535132: Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone |
|
|
| Completed | 4 | 201 | US, Europe, RoW | Oral Risperidone, Paliperidone ER | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | 07/08 | 07/08 | | |
NCT00206102: A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 4 | 1098 | US | quetiapine fumarate, Seroquel, ICI 204,636, risperidone | AstraZeneca | Schizophrenia, Schizoaffective Disorder | 10/08 | 10/08 | | |
NCT00299702: Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia |
|
|
| Completed | 4 | 355 | US | Abilify, Risperidal Consta | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Schizophrenia, Psychotic Disorders | 01/09 | 01/09 | | |
NCT00508157 / 2007-001217-42: A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome |
|
|
| Terminated | 4 | 125 | Europe, RoW | Aripiprazole, Abilify, BMS-337039, Continued Antipsychotic (Risperidone or Quetiapine or Olanzapine) | Bristol-Myers Squibb, Otsuka America Pharmaceutical | Metabolic Syndrome, Schizophrenia | 03/09 | 03/09 | | |
NCT00418873: Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward |
|
|
| Terminated | 4 | 39 | RoW | Zotepine, Lodopin®, Zoleptil®, Nipolept®, Risperidone, Risperdal® | Astellas Pharma Inc, Astellas Pharma Taiwan, Inc. | Schizophrenia | 12/09 | 12/09 | | |
NCT01010776: A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone |
|
|
| Completed | 4 | 223 | RoW | Paliperidone Extended Release (ER) | Janssen-Cilag Farmaceutica Ltda. | Schizophrenia | 12/09 | 12/09 | | |
NCT00934635: A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls |
|
|
| Terminated | 4 | 2 | Europe | Paliperidone ER, Oral risperidone, PET Scan | Janssen-Cilag G.m.b.H | Schizophrenia | 12/09 | 12/09 | | |
| Completed | 4 | 37 | Europe | amisulpride and risperidone | Sanofi | Schizophrenia | 01/10 | 01/10 | | |
NCT00946985: 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years |
|
|
| Terminated | 4 | 163 | US, Canada, Europe, RoW | paliperidone palmitate, oral risperidone | Ortho-McNeil Janssen Scientific Affairs, LLC | Schizophrenia | 03/10 | 03/10 | | |
NCT01284959: Different Safety Profile of Risperidone and Paliperidone Extended-release |
|
|
| Completed | 4 | 34 | RoW | risperidone, Rispedal, paliperidone ER, Invega, placebo | Chonbuk National University Hospital, AstraZeneca, Janssen Korea, Ltd., Korea, Korea Otsuka Pharmaceutical Co., Ltd., Sanofi-Synthelabo | Schizophrenia | 07/10 | 12/10 | | |
| Completed | 4 | 87 | Europe | ketamine, ketalar, risperidone, risperdal, saline, placebo risperidone, placebo risperdal | University of Manchester, Cardiff University, King's College London, P1vital Limited | Healthy Volunteers, Schizophrenia | 11/10 | 12/10 | | |
NCT00827840: Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia |
|
|
| Completed | 4 | 58 | RoW | Paliperidone ER, Invega, Risperidone, Risperdal | Chonnam National University Hospital, Janssen Korea, Ltd., Korea, Ministry of Health, Republic of Korea | Schizophrenia | 02/11 | 02/11 | | |
NCT01050582: A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children |
|
|
| Completed | 4 | 244 | US, Europe | Risperidone, Other atypical antipsychotic drugs | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia, Bipolar Disorder, Autistic Disorder, Conduct and Other Disruptive Behavior Disorders | 07/11 | 07/11 | | |
NCT00975611: Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation |
|
|
| Terminated | 4 | 6 | US | Amantadine Hydrochloride, USP, Symmetrel, Placebo, Symmetrel placebo | David C. Henderson, MD, Ortho-McNeil Janssen Scientific Affairs, LLC | Schizophrenia, Schizoaffective Disorder | 01/12 | 01/12 | | |
| Completed | 4 | 501 | US | iloperidone, Fanapt™ | Novartis | Schizophrenia | 01/12 | 01/12 | | |
NCT02075528: Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER |
|
|
| Completed | 4 | 41 | RoW | Paliperidone ER, 9-hydroxyrisperidone | Taipei City Hospital, Johnson & Johnson Taiwan Ltd, Taipei Institute of Pathology | Schizophrenia, Schizoaffective Disorder | 05/12 | 07/12 | | |
NCT01193166: Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital |
|
|
| Withdrawn | 4 | 0 | US | paliperidone palmitate, risperidone, olanzapine, aripiprazole, haloperidole, quetiapine, perphenazine, paliperidone | Ortho-McNeil Janssen Scientific Affairs, LLC | Schizophrenia | 09/12 | 09/12 | | |
NCT01592201: A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug |
|
|
| Terminated | 4 | 13 | RoW | Paliperdidone ER, Aripiprazole, olanzapine and risperidone (Antipsychotics) | Janssen Korea, Ltd., Korea | Schizophrenia | 06/13 | 06/13 | | |
NCT01157351: 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated |
|
|
| Completed | 4 | 450 | US | paliperidone, risperidone, haloperidole, perphenazine, aripiprazole, quetiapine, paliperidone palmitate, olanzapine | Janssen Scientific Affairs, LLC | Schizophrenia | 12/13 | 12/13 | | |
NCT01458379: Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia |
|
|
| Not yet recruiting | 4 | 50 | US | Paliperidone Palmitate, Risperidone | University of California, Los Angeles, Ortho-McNeil Janssen Scientific Affairs, LLC | Schizophrenia | 10/14 | 12/15 | | |
NCT01670071: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia |
|
|
| Terminated | 4 | 17 | RoW | Paliperidone extended-release, Paliperidone, Risperidone immediate-release, Risperidone IR | Johnson & Johnson Taiwan Ltd | Schizophrenia | 06/15 | 06/15 | | |
